AXSM
Axsome Therapeutics, Inc.
$134.00−1.95 (−1.43%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Nov 19, 2015 – Nov 18, 2026, Dividends reinvested
- Final balance
- $153,318
- CAGR
- +28.17%
- Max drawdown
- −86.65%
Trailing returns (%)
AXSM's average annual return was 33.24% over the last 10 years, through Nov 18, 2026. $10,000 in AXSM on Nov 18, 2016 grew to $176,316 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −14.73%
- 3M
- −37.87%
- 6M
- −41.07%
- YTD
- −26.63%
- 1Y
- −9.14%
Per year
- 3Y
- +30.80%
- 5Y
- +30.36%
- 10Y
- +33.24%
- Since 2015
- +28.17%
Annual returns
2015 from Nov 19 · 2026 through Nov 18
AXSM returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | −26.63% |
| 2025 | +115.86% |
| 2024 | +6.31% |
| 2023 | +3.19% |
| 2022 | +104.16% |
| 2021 | −53.63% |
| 2020 | −21.18% |
| 2019 | +3,565.25% |
| 2018 | −49.64% |
| 2017 | −17.04% |
| 2016 | −27.18% |
| 2015 from Nov 19 | +6.06% |
Metrics
Since 2015| Volatility | 90.88% |
|---|---|
| Sharpe ratio | 0.65 |
| Sortino ratio | 1.26 |
| Calmar ratio | 0.33 |
| Longest drawdown | 5.1 years |
Worst drawdowns
Since 2015| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −86.6% | Jan 2016 | Dec 2018 | Mar 2019 | 3.2 years |
| −81.3% | Dec 2019 | Aug 2021 | Jan 2025 | 5.1 years |
| −49.1% | Jun 2026 | Nov 2026 | Not yet | 5 months so far |
| −42.7% | Sep 2019 | Oct 2019 | Nov 2019 | 2 months |
| −30.6% | Feb 2025 | Apr 2025 | Nov 2025 | 8 months |